⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SUPN News
Supernus Pharmaceuticals, Inc.
Form 8-K
sec.gov
INDV
SUPN
Newron Provides Update on Phase 3 ENIGMA-TRS 2 Study
globenewswire.com
SUPN
Are ITGR, BZH, SUPN Obtaining Fair Deals for their Shareholders?
prnewswire.com
BZH
SUPN
ITGR
Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN
businesswire.com
SUPN
INDV
Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN
businesswire.com
SUPN
INDV
Newron presents H1 2026 results and provides corporate update
globenewswire.com
SUPN
Ogłoszono finalistów 23. edycji Stevie® Awards for Women in Business
prnewswire.com
IBM
AMZN
GOOGL
MSFT
NVDA
UNH
TMDX
SUPN
Newron Reports Subscription for EUR 5.5 Million of Shares by Investor Group as Part of Up to EUR 38 Million Total Financing to Advance Phase 3 Evenamide Program
globenewswire.com
SUPN
Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
SUPN
Supernus Pharmaceuticals to Participate in September Investor Conferences
globenewswire.com
SUPN